Filing Details
- Accession Number:
- 0001209191-23-045479
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-11 17:28:57
- Reporting Period:
- 2023-08-09
- Accepted Time:
- 2023-08-11 17:28:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc. | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1743122 | Samantha Prout | C/O Amicus Therapeutics, Inc. 3675 Market Street Philadelphia PA 19104 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-09 | 2,376 | $10.04 | 139,379 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-08-09 | 5,040 | $9.55 | 144,419 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-08-09 | 10,592 | $10.03 | 155,011 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-08-09 | 18,901 | $12.11 | 173,912 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-08-09 | 36,909 | $14.01 | 137,003 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2023-08-09 | 2,376 | $0.00 | 2,376 | $10.04 |
| Common Stock | Stock Options (right to buy) | Disposition | 2023-08-09 | 5,040 | $0.00 | 5,040 | $9.55 |
| Common Stock | Stock Options (right to buy) | Disposition | 2023-08-09 | 10,592 | $0.00 | 10,592 | $10.03 |
| Common Stock | Stock Options (right to buy) | Disposition | 2023-08-09 | 18,901 | $0.00 | 18,901 | $12.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-01-02 | No | 4 | M | Direct | |
| 2,526 | 2030-01-02 | No | 4 | M | Direct | |
| 3,176 | 2030-04-15 | No | 4 | M | Direct | |
| 37,810 | 2032-01-14 | No | 4 | M | Direct |
Footnotes
- This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.10 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- All of these options were fully vested and exercisable as of the transaction date.
- As of August 9, 2023, 5,985 options were fully vested and exercisable and 1,581 remained unvested from this individual 2020 grant.
- As of August 9, 2023, 11,164 options were fully vested and exercisable and 2,604 remained unvested from this individual 2020 grant.
- As of August 9, 2023, 22,444 options were fully vested and exercisable and 34,267 remained unvested from this individual 2022 grant.
Billionaire Hedge Funds
